These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10148127)

  • 1. Current trends: evolving concepts in transfusion medicine. Leukoreduced blood components: "you can filter now or you can filter later.".
    Dzik WH
    Transfus Sci; 1992 Apr; 13(2):207-10. PubMed ID: 10148127
    [No Abstract]   [Full Text] [Related]  

  • 2. Biocompatibility of leukocyte removal filters during bedside leukocyte filtration of red cell concentrates.
    Gu YJ; Obster R; de Haan J; Huet RC; van Oeveren W
    Transfus Sci; 1992; 13(4):467-72. PubMed ID: 10147741
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality control of leucoreduced cellular blood components in France.
    Chabanel A; Andreu G; Carrat F; Hervé P
    Vox Sang; 2002 Feb; 82(2):67-71. PubMed ID: 11906669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced components.
    Dumont LJ
    Transfus Sci; 1998 Dec; 19(4):377-80. PubMed ID: 10351162
    [No Abstract]   [Full Text] [Related]  

  • 5. Current trends in blood component therapy: the evolution of a safer, more effective product.
    Baranowski L
    J Intraven Nurs; 1992; 15(3):136-51. PubMed ID: 1608013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Washing and filtration of blood components: which indications are established?].
    Neppert J
    Beitr Infusionsther; 1993; 31():64-9. PubMed ID: 7693266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study.
    de Pont AC; Oudemans-van Straaten HM; Roozendaal KJ; Zandstra DF
    Crit Care Med; 2000 Feb; 28(2):421-5. PubMed ID: 10708177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma products and prion removal: "Is you is or is you ain't …?".
    Foster PR
    Transfusion; 2013 Sep; 53(9):1873-5. PubMed ID: 24015937
    [No Abstract]   [Full Text] [Related]  

  • 9. A prion reduction filter does not completely remove endogenous prion infectivity from sheep blood.
    McCutcheon S; Alejo Blanco AR; Tan BC; González L; Martin S; Mallinson G; Appleford NE; Turner ML; Manson JC; Houston EF
    Transfusion; 2015 Sep; 55(9):2123-33. PubMed ID: 26032915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials in Transfusion Medicine and hemotherapy: Worth moving forward in evaluating 'fresh' versus 'old' blood cell components?
    Garraud O
    Transfus Apher Sci; 2017 Feb; 56(1):98-99. PubMed ID: 28117175
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood component therapy.
    Fasano R; Luban NL
    Pediatr Clin North Am; 2008 Apr; 55(2):421-45, ix. PubMed ID: 18381094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood banking and transfusion medicine for the nephrologist.
    Wehrli G
    Semin Dial; 2012; 25(2):114-8. PubMed ID: 22276991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bibliography. Current world literature. Transfusion medicine.
    Curr Opin Hematol; 2006 Nov; 13(6):499-502. PubMed ID: 17120328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trauma and transfusion in time].
    Sundin P; Östlund A
    Lakartidningen; 2016 Jan; 113():. PubMed ID: 26785269
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a bifunctional filter for prion protein and leukoreduction of red blood cell components.
    Yokomizo T; Kai T; Miura M; Ohto H
    Transfusion; 2015 Feb; 55(2):330-6. PubMed ID: 25178436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of a new dual screen microaggregate filter.
    Napychank PA; McDonough W; Simon TL; Snyder EL
    Transfus Sci; 1991; 12(1-2):101-7. PubMed ID: 10149539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion.
    Nerlich S
    Aust Nurs J; 1998 Jun; 5(11):suppl i-iv. PubMed ID: 10639966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of flow cytometry in transfusion medicine.
    Freedman J; Lazarus AH
    Transfus Med Rev; 1995 Apr; 9(2):87-109. PubMed ID: 7795335
    [No Abstract]   [Full Text] [Related]  

  • 19. Component therapy to cellular therapy and beyond- a Darwinian approach to transfusion medicine.
    Snyder EL
    Transfusion; 2008 Sep; 48(9):2000-7. PubMed ID: 18694467
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood component therapy and changing transfusion triggers.
    Williford PD; Bensky KP
    CRNA; 1994 Nov; 5(4):139-50. PubMed ID: 7881351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.